Xiaoxuan Shanlang Dangjian Pian (消旋山莨菪碱片)消旋山莨菪碱片

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

消旋山莨菪是一种在国家药监局注册认定的药品。该药品含有消旋山莨菪-fb905a72等成分。

该药品关联的活性成分包括:消旋山莨菪Xiaoxuan Shanlang Dang。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:上海衡山药业有限公司Chinese legal name: 上海衡山药业有限公司。

您可以探索含有相同成分的其他药品:消旋山莨菪-fb905a72成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 消旋山莨菪碱片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 消旋山莨菪Xiaoxuan Shanlang Dang.

Manufacturers recorded for this product: 上海衡山药业有限公司Chinese legal name: 上海衡山药业有限公司.

Explore other medicines containing the same ingredient: 消旋山莨菪 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 消旋山莨菪碱片Recorded Chinese name: 消旋山莨菪碱片
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 10mg10 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 上海衡山药业有限公司Chinese legal name: 上海衡山药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H31020902

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H31020902

Manufacturer

Chinese legal name: 上海衡山药业有限公司

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H31020902

生产企业

上海衡山药业有限公司

适应症

抗胆碱药,临床主要用于解除平滑肌痉挛、胃肠绞痛、胆道痉挛以及有机磷中毒等。

用法用量

口服。成人:每次5~10mg,每日3次。小儿:每次0.1~0.2mg,每日3次。

不良反应

常见的有:口干、面红、视物模糊等;少见的有:心跳加快、排尿困难等;上述症状多在1~3小时内消失。用量过大时可出现阿托品样中毒症状。

禁忌

出血性疾病、脑出血急性期、青光眼、前列腺肥大、尿潴留患者禁用。

注意事项

1.低充盈压的急性心肌梗死、主动脉或二尖瓣狭窄、体位性低血压、肾功能不全者慎用。
2.不应突然停止用药,以避免反跳现象。

贮藏

密封

规格

10mg

证据Evidence

  • 批准文号: 国药准字H31020902
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.